Aurinia Pharmaceuticals, Inc. (AUPH)
14.45
+0.01
(+0.07%)
USD |
NASDAQ |
Feb 09, 13:58
Aurinia Pharmaceuticals Market Cap : 1.905B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 90.17M |
| Edesa Biotech, Inc. | 8.084M |
| Lexaria Bioscience Corp. | 17.68M |
| Xenon Pharmaceuticals, Inc. | 3.241B |
| ProMIS Neurosciences, Inc. | 28.80M |
Market Cap Related Metrics
| PE Ratio | 25.75 |
| PS Ratio | 7.671 |
| Price to Book Value | 5.208 |
| Price to Free Cash Flow | 16.94 |
| Price | 14.45 |
| Earnings Yield | 3.88% |
| Operating PE Ratio | 21.00 |
| Normalized PE Ratio | 22.51 |